Colchicine and macrolides: a cohort study of the risk of adverse outcomes associated with concomitant exposure

MLA

Malinda S. Tan, et al. “Colchicine and Macrolides: A Cohort Study of the Risk of Adverse Outcomes Associated with Concomitant Exposure.” Rheumatology International, vol. 42, Sept. 2022, pp. 2253–59. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........ff52a336750aaee7ceae82172320ef76&authtype=sso&custid=ns315887.

APA

Malinda S. Tan, Ainhoa Gomez-Lumbreras, Lorenzo Villa-Zapata, & Daniel C. Malone. (2022). Colchicine and macrolides: a cohort study of the risk of adverse outcomes associated with concomitant exposure. Rheumatology International, 42, 2253–2259.

Chicago

Malinda S. Tan, Ainhoa Gomez-Lumbreras, Lorenzo Villa-Zapata, and Daniel C. Malone. 2022. “Colchicine and Macrolides: A Cohort Study of the Risk of Adverse Outcomes Associated with Concomitant Exposure.” Rheumatology International 42 (September): 2253–59. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........ff52a336750aaee7ceae82172320ef76&authtype=sso&custid=ns315887.